Infections of the Central Nervous System and Child Development in Sub-Saharan Africa

Abstract: Infectious diseases contribute significantly to child mortality in Africa; however, mortality rates only represent part of the problem. Among those who survive, cognitive, educational, and behavioral impairments have been reported. In the current chapter, I highlight the neurocognitive deficits, mental health problems, and poor educational outcomes associated with exposure to infectious diseases early in life. Special attention is paid to outcomes of HIV-infected children and children exposed to malaria. The chapter concludes by highlighting two approaches to intervention that have been observed to remediate some of the adverse effects of exposure to infections. Given the prevalence of infectious diseases in the African context, there are huge adverse effects and loss in human potential associated with childhood infectious diseases; identifying points of interventions and implementing evidence-based intervention for children infected with these conditions need to be a priority for applied developmental sciences

Growth and Neurodevelopment of HIV-Exposed Uninfected Children: a Conceptual Framework

This is a post-peer-review, pre-copyedit version of an article published in Current HIV/AIDS Reports. The final authenticated version is available online at: https://doi.org/10.1007/s11904-019-00459-0”

Streptococcus suis

Streptococcus suis is an important pathogen causing economic problems in the pig industry. Moreover, it is a zoonotic agent causing severe infections to people in close contact with infected pigs or pork-derived products. Although considered sporadic in the past, human S. suis infections have been reported during the last 45 years, with two large outbreaks recorded in China. In fact, the number of reported human cases has significantly increased in recent years. In this review, we present the worldwide distribution of serotypes and sequence types (STs), as determined by multilocus sequence typing, for pigs (between 2002 and 2013) and humans (between 1968 and 2013). The methods employed for S. suis identification and typing, the current epidemiological knowledge regarding serotypes and STs and the zoonotic potential of S. suis are discussed. Increased awareness of S. suis in both human and veterinary diagnostic laboratories and further establishment of typing methods will contribute to our knowledge of this pathogen, especially in regions where complete and/or recent data is lacking. More research is required to understand differences in virulence that occur among S. suis strains and if these differences can be associated with specific serotypes or STs